Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Marksans Pharma acquires Teva's manufacturing site in Goa - The Economic Times
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
New York could get $524M under opioid settlements with Teva - ABC News
Allergan to own 10% stake in Teva
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
TEVA: Can Teva Pharmaceutical Stock Continue to Rebound in 2021?